Sara Jacobs, Democrat of San Diego's 51st district, is generating more buzz calling out the Iran war narrative than she is filing financial disclosures. But Blind Trust doesn't cover the speech. We cover the trades. And in early May, Jacobs sold between $500,000 and ,000,000 in Qualcomm on May 6, then did it again on May 7. Two days. Same stock. Up to $2 million out the door. She sits on the House Committee on Armed Services and the House Committee on Foreign Affairs. She is not on a financial services committee. What she does have, per the committee_overlap_trades flag in our system, is a Technology overlap on both QCOM sales. That's the thing worth looking at.
The News: Jacobs vs. the Administration's Iran Story
On social this week, Jacobs has been doing what the San Diego Democrat does best: pushing back loudly on foreign policy. A post circulating on Bluesky quotes her responding to Secretary Marco Rubio's declaration that "the war is over" and that the U.S. is "no longer conducting sustained strikes in Iran." Her reply, paraphrased across multiple shares: the American people aren't stupid, and they can see this war for what it is.
There's also a separate thread going around, her pushing back on the administration using American passports as what she called "personal propaganda material." Both are vintage Jacobs: Armed Services member, Foreign Affairs voice, not shy about saying the quiet part out loud when the administration is spinning.
None of that is why you're reading this.
The Trades: Qualcomm, Twice, Back to Back
On May 6 and May 7, 2026, Jacobs's disclosure filings show two sales of Qualcomm ($QCOM), each in the $500,000 to ,000,000 range. That's the disclosed range, which is how Congress reports these things. The actual number could be anywhere between million and $2 million combined. We don't get more precision than that. Members are required to disclose. They are not required to tell you the exact dollar amount, explain the timing, or justify the position to anyone.
Two trades. Same ticker. Consecutive days. That's the full picture of Jacobs's trading activity over the last 90 days.
Qualcomm is a San Diego company. Jacobs represents a San Diego district. That overlap is, at minimum, cosmetically awkward. It's also worth knowing because Qualcomm is a semiconductor and wireless technology firm whose business is deeply tied to defense contracts, chip export policy, and the kind of geopolitical maneuvering that Jacobs's committee assignments put her adjacent to on a regular basis.
The Committee Overlap: This One Actually Counts
A lot of congressional trading stories collapse when you check the committee assignments. A member votes on a banking bill; turns out they're on Agriculture, not Financial Services. The overlap evaporates.
This one doesn't evaporate quite the same way.
Jacobs sits on Armed Services (including the Intelligence and Special Operations subcommittee) and Foreign Affairs. Qualcomm's business intersects with both: the company's chips are in military hardware, its export licenses are subject to Commerce and State Department review, and the ongoing semiconductor cold war with China is exactly the kind of issue that Armed Services and Foreign Affairs members get briefings on. Our system flags both QCOM sales as carrying a Technology committee overlap.
To be precise about what that means and what it doesn't: this is a subject-matter adjacency flag, not an allegation. Jacobs's committees don't have formal jurisdiction over Qualcomm's stock price. She's not on the House Science, Space, and Technology Committee or Energy and Commerce. But the line between "legislative oversight" and "informed about the company's operating environment" is not a bright one when your day job involves classified briefings on chip warfare and export controls.
The receipts are public. Make of them what you make of them.
The Alpha Record: Mixed, and That's the Honest Answer
Here's what the numbers actually show. Blind Trust has scored both QCOM trades on 30-day excess return versus the S&P 500. The May 6 sale: +4.2% alpha. The May 7 sale: -3.5% alpha. Record: 1 positive out of 2 scored trades. Mean alpha across both: +0.3%.
That is not a stat line that supports a "master trader" narrative. One trade timed well. One didn't. The average excess return rounds to roughly flat. The full record is two trades, and the two trades go in opposite directions on performance. Anyone trying to build a "she's printing alpha on tech calls" argument from this data is working with two data points and an agenda.
What the data does show is that she sold a significant position in a San Diego semiconductor company over two days, and the month-over-month result depended heavily on which of the two days you focus on. The May 6 sale looks reasonably timed in retrospect. The May 7 sale, less so.
That's the honest version. We don't shade the numbers.
The Votes: Banking Bills She Has No Committee Stake In
On May 20, Jacobs voted Yea on four banking and finance-adjacent bills that passed the House: the American Access to Banking Act (H.R. 4544), the Community Bank Deposit Access Act of 2025 (H.R. 5317), the Keeping Deposits Local Act (H.R. 3234), and the 25th Anniversary of 9/11 Commemorative Coin Act (H.R. 1993).
These are floor votes, not committee actions. Jacobs is not on the House Financial Services Committee. She has no special oversight position on any of these bills. She voted like most members vote: as a floor participant on legislation outside her primary remit. Our system flags no vote-trade overlaps between these votes and her QCOM sales. There's no timing story here. The trades came first, the votes came after, and the votes are about banking, not semiconductors.
She also voted Nay on both the Veterans 2nd Amendment Protection Act (H.R. 1041) and the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act of 2026 (H.R. 6047) on May 21, while voting Yea on the Fiscal Year 2025 Veterans Affairs Major Medical Facility Authorization Act (S. 2393) the day before. Her Armed Services membership makes veterans legislation directly relevant to her committee work. Neither of those votes touches her portfolio in any way the data shows.
The Context Nobody Mentions
Qualcomm has had a complicated few months. Export control tightening, chip restriction conversations, the perpetual will-they-won't-they of U.S.-China tech policy. These are not obscure concerns for someone on Armed Services and Foreign Affairs. A member in those rooms hears about chip supply chain vulnerabilities before the average CNBC viewer does.
We're not saying that's what happened. The disclosure filings don't say that. The timing doesn't prove that. What the timing does is raise the question that the reader is already asking.
The system allows this. Members are required to disclose within 45 days. They are not required to divest, recuse, abstain, or explain. Jacobs filed. The filings are sitting there, doing exactly what they were designed to do: tell the public what happened, stripped of context, without requiring anyone to provide that context.
The gap between "filed" and "explained" is where Blind Trust lives.
What We Know and Don't Know
What we know: Jacobs sold up to $2 million in Qualcomm over two consecutive days in early May. Both trades carry a Technology committee overlap. The 30-day alpha on the two trades is +4.2% and -3.5%, respectively. Mean alpha: +0.3%. She sits on committees that hear about semiconductor export policy and defense technology. There are no flagged vote-trade overlaps. She is currently very publicly pushing back on the administration's foreign policy claims.
What we don't know: why she sold when she sold, whether the position was being unwound for portfolio reasons, estate planning, or anything else. Congressional disclosures don't require that explanation. They never have.
One thing is clear: selling a combined M-$2M in a hometown defense-adjacent tech firm across two days, while sitting on Armed Services Intelligence and Special Operations, is not a nothing disclosure. It's the kind of filing that earns a second look. We gave it one.
Readers get to bring their own opinion.